Pandemic Influenza A H1N1 (2009) Virus: Lessons from the Past and Implications for the Future
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
The recent pandemic by novel influenza A (H1N1) 2009 (pH1N1) virus is an emerging viral infection, being of significant international concern and requires intensive research. The virus spread in pandemic proportions, and continues to be in the post-pandemic phase. Since, the pH1N1 is still circulating in the community, monitoring is required during the post-pandemic period. The pH1N1 defied influenza seasonality and rapidly became dominant over the seasonal influenza viruses. This new strain was antigenically different from the seasonal H1N1 influenza strains due to the genetic re-assortment. Surprisingly, this new reassortant virus emerged at the end of influenza season, caused a sudden toll of mild illness and is now co-circulating with the seasonal strains. The recent outbreak of pH1N1 consolidates the fact that a new reassortant virus may have originated in animal reservoirs and got transferred to human who were in close contact with these animals. There is a continued need for multisite surveillance to detect potentially dangerous influenza strains, which may emerge and establish themselves in human population. This review is an attempt to address the lessons learnt from the recent influenza pandemic and the future implications for prevention and control of influenza.
- Barry JM. The great influenza. The story of the deadliest pandemic in history. London: Penguin Books; 2005.
- Basler CF, Aguilar PV. Progress in identifying virulence determinants of the 1918 H1N1 and the Southeast Asian H5N1 influenza A viruses. Antiviral Res. 2008;79:166–78. CrossRef
- Baz M, Abed Y, Papenburg J, Bouhy X, Hamelin M, Boivin M. Emergence of oseltamivir-resistant pandemic H1N1 virus during prophylaxis. N Eng J Med. 2009;361:2296–7. CrossRef
- Evaluation of rapid influenza diagnostic tests for detection of novel influenza A (H1N1) virus—United States, 2009. MMWR Morb Mortal Wkly Rep. 2009;58:826–9.
- Chen GW, Shih SR. Genomic signatures of influenza A pandemic (H1N1) 2009 virus. Emerg Infect Dis. 2009;15:1897–903.
- Chia-Lin L, Chiang LC, Cheng LH, Liaw CC, El-Raze MAH, Chang FR, et al. Influenza A (H1N1) antiviral and cytotoxic agents from Ferula assa-foetida. J Nat Prod. 2009;72:1568–72. CrossRef
- Eichner M, Schwehm M, Duerr HP, Witschi M, Koch D, Brockmann SO, Vidondo B. Antiviral prophylaxis during pandemic influenza may increase drug resistance. BMC Infect Dis. 2009;9:4. CrossRef
- Garten RJ, Davis CT, Russel CA, Shu B, Lindstrom S, et al. Antigenic and genetic characteristics of swine-origin 2009 A (H1N1) influenza viruses circulating in humans. Science. 2009;325:197–201. CrossRef
- Gibbs AJ, Armstrong JS, Downie JC. From where did the 2009 ‘swine-origin’ influenza A virus (H1N1) emerge? Virol J. 2009;6:207. CrossRef
- Glass RJ, Glass LM, Beyeler WE, Min HJ. Targeted social distancing design for pandemic influenza. Emer Infect Dis. 2006;12:1671–81. CrossRef
- Glezen WP. Containing the novel influenza A (H1N1) virus. Clin Infect Dis. 2010;50:869–70. CrossRef
- Goldkind SF, Sahin L, Gallauresi B. Enrolling pregnant women in research—lessons from the H1N1 influenza pandemic. N Engl J Med. 2010;362:2221–3. CrossRef
- Guan Y, Shortridge KF, Krauss S, Webster RG. Molecular characterization of H9N2 influenza viruses: were they the donors of the ‘‘internal’’ genes of H5N1 viruses in Hong Kong? Proc Natl Acad Sci USA. 1999;96:9363–7. CrossRef
- Hai R, Schmolke M, Varga ZT, Manicassamy B, Wang TT, et al. PB1-F2 expression by the 2009 pandemic H1N1 influenza virus has minimal impact on virulence in animal models. J Virol. 2010;84:4442–50. CrossRef
- Hill A, Guralnick R, Wilson M, Habib F, Janies D. Evolution of drug resistance in multiple distinct lineages of H5N1 avian influenza. Infect Genet Evol. 2009;9:169–78. CrossRef
- Kashyap AK, Steel J, Rubrum A, Estelles A, Briante R, et al. Protection from the 2009 H1N1 pandemic influenza by an antibody from combinatorial survivor-based libraries. PLoS Pathog. 2010;6:1000990. CrossRef
- Khanna M, Kumar P, Choudhary K, Kumar B, Vijayan VK. Emerging influenza virus: a global threat. J Biosci. 2008;33:475–82. CrossRef
- Khanna M, Kumar B, Gupta N, Kumar P, Vijayan VK, Kaur H. Pandemic swine influenza virus (H1N1): a threatening evolution. Indian J Microbiol. 2009;49:365–9. CrossRef
- Lindstrom SE, Cox NJ, Klimov A. Genetic analysis of human H2N2 and early H3N2 influenza viruses, 1957–1972: evidence for genetic divergence and multiple reassortment events. Virology. 2004;328:101–19. CrossRef
- Lowen AC, Mubareka S, Steel J, Palese P. Influenza virus transmission is dependent on relative humidity and temperature. PLoS Pathog. 2007;193(10):1470–4.
- Memoli MJ, Hrabal RJ, Hassantoufighi A, Eichelberger MC, Taubenberger JK. Rapid selection of oseltamivir- and peramivir-resistant pandemic H1N1 virus during therapy in 2 immunocompromised hosts. Clin Infect Dis. 2010;50:1252–5. CrossRef
- Merler S, Ajelli M, Rizzo C. Age-prioritized use of antivirals during an influenza pandemics. BMC Infect Dis. 2009;9:117. CrossRef
- Mishra AC, Chadha MS, Choudhary ML, Potdar VA. Pandemic Influenza (H1N1) 2009 Is Associated with Severe Disease in India. PLoS One. 2010;5:e10540. CrossRef
- Moscona A. Global transmission of oseltamivir-resistant influenza. N Engl J Med. 2009;360:953–6. CrossRef
- Ariano RE, Sitar DS, Zelenitsky SA, Zarychanski R, Pisipati A, Ahern S, Kanji S, Rello L, Kumar A. Enteric absorption and pharmacokinetics of oseltamivir in critically ill patients with pandemic (H1N1) influenza. CMAJ. 2010;182:357–63.
- Operario DJ, Moser MJ, St.George K. Highly sensitive and quantitative detection of the H274Y oseltamivir resistance mutation in seasonal A/H1N1 influenza. J Clin Microbiol. 2010;48:3517–24. CrossRef
- Poalillo FE, Geiling J, Jimenez EJ. Healthcare personnel and nosocomial transmission of pandemic 2009 influenza. Crit Care Med. 2010;38:98–102. CrossRef
- Rambaut A, Holmes E. The early molecular epidemiology of the swine-origin A/H1N1 human influenza pandemic. PLoS Curr. 2009;1:RRN1003. CrossRef
- Shih SR, Chu TY, Reddy GR, Tseng SN, Chen HL, Tang WF, et al. Pyrazole compound BPR1P0034 with potent and selective anti-influenza virus activity. J Biomed Sci. 2010;17:13. CrossRef
- Siston AM, Rasmussen SA, Honein MA, Fry AM, Seib K, Callaghan WM, et al. Pandemic 2009 influenza A (H1N1) virus illness among pregnant women in the United States. JAMA. 2010;303:1517–25. CrossRef
- Tandale BV, Pawar SD, Gurav YK, Chadha MS, Koratkar SS, et al. Seroepidemiology of pandemic influenza A (H1N1) 2009 virus infections in Pune, India. BMC Infect Dis. 2010;10:255. CrossRef
- Torres JP, O’Ryan M, Herve B, Espinoza R, Acuna G, Manalich J, et al. Impact of the novel influenza A (H1N1) during the 2009 autumn‐winter season in a large hospital setting in Santiago, Chile. Clin Infect Dis. 2010;50:860–8. CrossRef
- Triana-Baltzer GB, Gubareva LV, Nicholls JM, Pearce MB, Mishin VP. Novel pandemic influenza A (H1N1) viruses are potently inhibited by DAS181, a sialidase fusion protein. PLoS One. 2009;4(11):7788. CrossRef
- Wilson K, Brownstein JS, Fidler DP. Strengthening the international health regulations: lessons from the H1N1 pandemic. Health Policy Plan. 2010;25:505–9. CrossRef
- Wu JT, Leung GM, Lipsitch M, Cooper BS, Riley S. Hedging against antiviral resistance during the next influenza pandemic using small stockpiles of an alternative chemotherapy. PLoS Med. 2009;6:1000085. CrossRef
- Pandemic Influenza A H1N1 (2009) Virus: Lessons from the Past and Implications for the Future
Indian Journal of Virology
Volume 23, Issue 1 , pp 12-17
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Influenza A H1N1 virus
- Antiviral therapy